dihydromorphine
← Previous: dihydroetorphine | 🏠 All Substances | 📊 Complete Table | Next: dimenoxadol →
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule I |
| Reason | Controlled substance: Schedule I |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule I (DEA Controlled Substance List: Schedule I) |
| Added to Database | December 30, 2025 |
| Source Last Updated | March 14, 2024 |
| GUID | 4a6390ff-9c9e-4193-88db-a3e4f57165a2 |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: C3S5FRP6JW · CAS: 509-60-4
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C17H21NO3 |
| Molecular Weight | 287.35 g/mol |
| IUPAC Name | (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol |
| InChIKey | IJVCSMSMFSCRME-KBQPJGBKSA-N |
📊 Complete Table | 🏠 All Substances
Substance 339 of 880